Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCX140-B in diabetic nephropathy
NCT01447147Phase 2Completed
- Sponsor
- Amgen
- Start
- Oct 2011
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of ilacirnon in diabetic nephropathy (DN), sponsored by Amgen. Started Oct 2011; status: completed.
02
Drugs
ilacirnon
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT01447147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01447147.